Member Info for neilrich3

There's been no reduction in Tier 1 PCR testing within the UK, which is where we supply the NHS. Swings and Roundabouts with regards to the travel industry, fortunately if travelling to the Middle East or the USA you still require a PCR, still very much a market within the UK for PCR testing and fortunately an even bigger market in the rest off the world.

Naewise, That's not true most of the Board are holding shares and James McCarthy was buying at >£9 and spent more than £80k.

The fact that we have only tweeted about LFT of late, suggests that every other product is flying off the shelves and that demand more than meets supply. Genesis, Pro-mate, SNPsig are all very much in demand globally.

Message Today from the WHO: The Covid-19 pandemic "is far from over", the director general of the World Health Organization (WHO) warned on Tuesday, warning against the idea that the Omicron variant is benign.

Might be me, however within the past 24 hours the reference/link to Antigen Self Test has been removed from the Novacyt/Microgen website, too much of a coincidence for my liking having discussed here upon the chat.

B2HS2L, Don't agree, I've seen the video and Kevin is talking in the future tense. In fact Kevin starts the sentence before "In the future...."
In my opinion, at present there's no direct sales force within the USA, we'd have seen the vacancies advertised and we'd have come across the employed individuals upon linkedin. It would be madness to put a North America sales team in place without the approvals, a sales team to sell RUO and EUA products.

SBI reports numbers significantly ahead of market expectations. There’s been much debate upon here that NCYT would have had to update the market before now if we were to announce numbers ahead of previous guidance, I’m thinking not, next weeks numbers shall provide the update ahead of the Full Year results, nothing to stop NCYT doing the same next week and announcing numbers 40% ahead of expectations.

I don't believe that the direct sales force within the USA has materialised, if it had, there'd be evidence upon the likes of Linkedin. From what I could see, we employed two people within the USA, one of which was Liz, however Liz is now working for YGEN. Also, many of our products within the USA are for RUO, therefore would make no sense to employ a Sales team until such time that the FDA approvals for our products are in place.

To be fair if NCYT had been trading upon the same multiple as SBI the NCYT share price would have been well North of £15.00!

Hadn't noticed previously, however the Microgen Website lists Pathflow Rapid Antigen Pro and Antigen Self Test. For the Self Test it states email for details, perhaps the launch of the Self Test is close!

https://www.youtube.com/watch?v=WuObc1ke6aE

Based upon the known info below, Q machine production capacity increased significantly in the latter part of 2020, potentially as high as 1500/month.

3 August 2020 the quoted production for Q machines was 300/month.

16 Nov 2020 Further to the announcement on 15 October 2020 when Novacyt acquired IT-IS International, the Company has significantly increased the manufacturing capability of IT-IS to manage the growing demand for its q16 and q32 instruments. From November 2020, the Company has scaled-up manufacturing capacity for instrument production more than five-fold, with further expansion planned, depending on continued demand.

Rome wasn't built in a Day. Personally I'm happy to wait for the finished product, the alternative David delivers some half baked plan with little substance, been there before ....when GM announced the LFT and the potential for 'substantial' additional revenue from the Professional use and Home use LFT with an initial production capacity of 1m a week....GM failed to deliver and we are still waiting. Clearly much going on behind the scenes, expansion of the Commercial team for one, once David reveals the new plan, I'm sure that he shall be trumpeting his vision from every available angle.

NCYT is in the process of assembling a Global Sales force, clearly a new plan is currently being formulated, they already have a portfolio of products, plus new products under development.....I think exciting times ahead. David shall reveal the plan when he's ready and not before.

https://www.linkedin.com/in/hamed-djoued-ab8a93188/?originalSubdomain=fr
https://www.linkedin.com/in/luc-nubel-63132915/?originalSubdomain=fr
I've not noticed these before, therefore can't confirm whether new appointments or not.

We've heard about an end to testing before, yet we reach record levels! I'd argee that it is unlikely to be sustainable, however the tests that they are referring to are the ones from China which the government are handing out for free. Testing shall continue in hospitals, care homes, for travel and within industry.

Adam still very much connected with Novacyt based upon his Linkedin Likes. Also, seem to remember that he featured in a promo video last year, certainly promoted quickly through the ranks at Novacyt, appears to have remained loyal.

Also, look at how revenues grew at Amryt under David as Chief Commercial Officer and then Chief Business Officer (a reward for his success?)

Soder, I disagree, DA was with Amryt for 6 years!! Don't forget that Amryt bought out Aegerion Pharmaceuticals where David started in 2015.

Disagree, check the accounts for Ajan's businesses, dormant companies. As Ajan has said himself replying to Graham 'thanks for the once in a lifetime opportunity'

Ajan got the push.

Yesterday Ajan replied individually to all the messages of goodwill, increasingly looking like this guy got the push.
Thank you Seden
It’s been great working with you. You have created a great team. Look forward to reading about your continued success and development

Thank you Daryl
Yes, ?? but unforgettable times

Happy New Year
Thank you Graham - greatly appreciate the once-in-a-lifetime opportunity and your support and mentorship